Joel Lewis
Known title: President and CEOCIK: 0001725595
Joel Lewis's purchase track record
Joel Lewis has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 4/24/2024 | GALT | $3K | -21.6% | -21.6% | +14.3% |
| 2/16/2023 | GALT | $2K | +10.0% | +15.3% | +6.8% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| GALT | ▼ Sell | Open Market | 37,698 | $135K | 1/6/2026 | View on chart |
| GALT | ▼ Sell | Open Market | 27,731 | $108K | 1/5/2026 | View on chart |
| GALT | ▲ Buy | Option Exercise | 84,000 | $0 | 1/2/2026 | View on chart |
| GALT | ▼ Sell | Open Market | 18,571 | $78K | 1/2/2026 | View on chart |
| GALT | ▲ Buy | Option Exercise | 7,829 | $22K | 12/17/2025 | View on chart |
| GALT | ▼ Sell | Open Market | 7,829 | $55K | 12/17/2025 | View on chart |
| GALT | ▲ Buy | Option Exercise | 6,783 | $16K | 11/18/2025 | View on chart |
| GALT | ▼ Sell | Open Market | 6,783 | $42K | 11/18/2025 | View on chart |
| GALT | ▲ Buy | Option Exercise | 15,680 | $37K | 11/17/2025 | View on chart |
| GALT | ▼ Sell | Open Market | 15,680 | $95K | 11/17/2025 | View on chart |
| GALT | ▲ Buy | Option Exercise | 1,867 | $4K | 11/10/2025 | View on chart |
| GALT | ▼ Sell | Open Market | 1,867 | $11K | 11/10/2025 | View on chart |
| GALT | ▲ Buy | Option Exercise | 200 | $478 | 11/5/2025 | View on chart |
| GALT | ▼ Sell | Open Market | 200 | $1K | 11/5/2025 | View on chart |
| GALT | ▲ Buy | Option Exercise | 14,420 | $34K | 11/4/2025 | View on chart |
| GALT | ▼ Sell | Open Market | 14,420 | $88K | 11/4/2025 | View on chart |
| GALT | ▲ Buy | Option Exercise | 1,300 | $3K | 11/3/2025 | View on chart |
| GALT | ▼ Sell | Open Market | 1,300 | $8K | 11/3/2025 | View on chart |
| GALT | ▲ Buy | Option Exercise | 14,000 | $33K | 9/12/2025 | View on chart |
| GALT | ▼ Sell | Open Market | 14,000 | $89K | 9/12/2025 | View on chart |
| GALT | ▲ Buy | Grant | 56,420 | $89K | 3/3/2025 | View on chart |
| GALT | ▲ Buy | Option Exercise | 56,000 | $0 | 12/23/2024 | View on chart |
| GALT | ▼ Sell | Open Market | 56,000 | $50K | 12/23/2024 | View on chart |
| GALT | ▲ Buy | Open Market | 1,000 | $3K | 4/24/2024 | View on chart |
| GALT | ▲ Buy | Grant | 152,584 | $299K | 3/1/2024 | View on chart |
| GALT | ▲ Buy | Grant | 11,606 | $19K | 12/29/2023 | View on chart |
| GALT | ▲ Buy | Grant | 12,042 | $19K | 12/15/2023 | View on chart |
| GALT | ▲ Buy | Grant | 9,880 | $19K | 11/30/2023 | View on chart |
| GALT | ▲ Buy | Grant | 10,303 | $19K | 11/15/2023 | View on chart |
| GALT | ▲ Buy | Grant | 9,444 | $19K | 10/31/2023 | View on chart |
| GALT | ▲ Buy | Grant | 10,035 | $20K | 10/13/2023 | View on chart |
| GALT | ▲ Buy | Grant | 10,035 | $19K | 9/29/2023 | View on chart |
| GALT | ▲ Buy | Grant | 10,947 | $19K | 9/15/2023 | View on chart |
| GALT | ▲ Buy | Grant | 11,010 | $19K | 8/31/2023 | View on chart |
| GALT | ▲ Buy | Grant | 12,042 | $19K | 8/15/2023 | View on chart |
| GALT | ▲ Buy | Grant | 12,844 | $19K | 7/31/2023 | View on chart |
| GALT | ▲ Buy | Grant | 11,820 | $19K | 7/14/2023 | View on chart |
| GALT | ▲ Buy | Grant | 13,380 | $19K | 6/30/2023 | View on chart |
| GALT | ▲ Buy | Grant | 13,196 | $19K | 6/15/2023 | View on chart |
| GALT | ▲ Buy | Grant | 12,272 | $19K | 5/31/2023 | View on chart |
| GALT | ▲ Buy | Grant | 11,748 | $19K | 5/15/2023 | View on chart |
| GALT | ▲ Buy | Grant | 10,947 | $19K | 4/28/2023 | View on chart |
| GALT | ▲ Buy | Grant | 9,585 | $19K | 4/14/2023 | View on chart |
| GALT | ▲ Buy | Grant | 9,175 | $19K | 3/31/2023 | View on chart |
| GALT | ▲ Buy | Grant | 10,140 | $19K | 3/15/2023 | View on chart |
| GALT | ▼ Sell | Tax Withholding | 75,529 | $156K | 3/1/2023 | View on chart |
| GALT | ▲ Buy | Grant | 9,308 | $19K | 2/28/2023 | View on chart |
| GALT | ▲ Buy | Open Market | 1,000 | $2K | 2/16/2023 | View on chart |
| GALT | ▲ Buy | Grant | 13,380 | $19K | 2/15/2023 | View on chart |
| GALT | ▲ Buy | Grant | 143,836 | $206K | 2/7/2023 | View on chart |
| GALT | ▲ Buy | Grant | 15,086 | $17K | 1/31/2023 | View on chart |
| GALT | ▲ Buy | Grant | 15,351 | $18K | 1/13/2023 | View on chart |
| GALT | ▲ Buy | Grant | 15,487 | $18K | 12/30/2022 | View on chart |
| GALT | ▲ Buy | Grant | 15,086 | $17K | 12/15/2022 | View on chart |
| GALT | ▲ Buy | Grant | 13,780 | $18K | 11/30/2022 | View on chart |
| GALT | ▲ Buy | Grant | 14,113 | $18K | 11/15/2022 | View on chart |
| GALT | ▲ Buy | Grant | 12,681 | $17K | 10/31/2022 | View on chart |
| GALT | ▲ Buy | Grant | 10,802 | $17K | 10/14/2022 | View on chart |
| GALT | ▲ Buy | Grant | 10,736 | $19K | 9/30/2022 | View on chart |
| GALT | ▲ Buy | Grant | 9,777 | $18K | 9/15/2022 | View on chart |
| GALT | ▲ Buy | Grant | 9,211 | $18K | 8/31/2022 | View on chart |
| GALT | ▲ Buy | Grant | 8,028 | $18K | 8/15/2022 | View on chart |
| GALT | ▲ Buy | Grant | 10,606 | $24K | 7/29/2022 | View on chart |
| GALT | ▲ Buy | Grant | 10,606 | $17K | 7/15/2022 | View on chart |
| GALT | ▲ Buy | Grant | 13,359 | $18K | 6/30/2022 | View on chart |
| GALT | ▲ Buy | Grant | 13,780 | $18K | 6/15/2022 | View on chart |
| GALT | ▲ Buy | Grant | 13,566 | $18K | 5/31/2022 | View on chart |
| GALT | ▲ Buy | Grant | 12,868 | $18K | 5/13/2022 | View on chart |
| GALT | ▲ Buy | Grant | 11,290 | $17K | 4/29/2022 | View on chart |
| GALT | ▲ Buy | Grant | 10,057 | $17K | 4/15/2022 | View on chart |
| GALT | ▲ Buy | Grant | 10,870 | $18K | 3/31/2022 | View on chart |
| GALT | ▲ Buy | Grant | 10,057 | $17K | 3/15/2022 | View on chart |
| GALT | ▲ Buy | Grant | 9,358 | $17K | 2/28/2022 | View on chart |
| GALT | ▲ Buy | Grant | 8,454 | $17K | 2/15/2022 | View on chart |
| GALT | ▲ Buy | Grant | 112,263 | $217K | 1/31/2022 | View on chart |
| GALT | ▲ Buy | Grant | 8,251 | $17K | 1/14/2022 | View on chart |
| GALT | ▲ Buy | Grant | 8,052 | $17K | 12/31/2021 | View on chart |
| GALT | ▲ Buy | Grant | 7,407 | $17K | 12/15/2021 | View on chart |
| GALT | ▲ Buy | Grant | 6,337 | $17K | 11/30/2021 | View on chart |
| GALT | ▲ Buy | Grant | 5,828 | $17K | 11/15/2021 | View on chart |
| GALT | ▲ Buy | Grant | 5,258 | $17K | 10/29/2021 | View on chart |
| GALT | ▲ Buy | Grant | 4,946 | $17K | 10/15/2021 | View on chart |
| GALT | ▲ Buy | Grant | 4,296 | $17K | 9/30/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
Galectin Clears Balance Sheet with $105M Debt Conversion
Galectin Therapeutics announced that a $105 million debt conversion has removed its outstanding debt, improving its balance sheet. The company still needs to secure a Phase 3 partnership to move its lead product forward. The move may reduce financial risk but the next milestone remains critical for the company's progress.
Galectin Clears Balance Sheet with $105M Debt Conversion. Galectin Therapeutics announced that a $105 million debt conversion has removed its outstanding debt, improving its balance sheet. The company still needs to secure a Phase 3 partnership to move its lead product forward. The move may reduce financial risk but the next milestone remains critical for the company's progress.